Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action (Q36466679)

14 August 2017

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action (English)

1 reference

14 August 2017

Kamby C

1

1 reference

14 August 2017

Andersen J

2

1 reference

14 August 2017

Ejlertsen B

3

1 reference

14 August 2017

Birkler NE

4

1 reference

14 August 2017

Rytter L

5

1 reference

14 August 2017

Zedeler K

6

1 reference

14 August 2017

Thorpe SM

7

1 reference

14 August 2017

Nørgaard T

8

1 reference

14 August 2017

Rose C

9

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 1988

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

58

1 reference

14 August 2017

4

1 reference

14 August 2017

480-486

1 reference

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The pathogenesis of cancer metastasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The clinical course of bone metastases from breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The clonal evolution of tumor cell populations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Analysis of reproducibility of subjective grading systems for breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The surgical implications of estrophile protein estimations in carcinoma of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

The curability of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Prognostic implication of estrogen receptor content in breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Survival after first recurrence in breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Organisation of the Danish adjuvant trials in breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246791

Stage and pattern of metastases in patients with breast cancer

21 September 2018

1 reference

12 December 2020

Is there an increased risk?

1 reference

12 December 2020

Clinical application of estrogen receptor in breast cancer

1 reference

12 December 2020

Estrogen receptor: A prognostic factor in breast cancer

1 reference

12 December 2020

Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer

1 reference

12 December 2020

Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy

1 reference

12 December 2020

Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer

1 reference

12 December 2020

Assessment of response of bone metastases to systemic treatment in patients with breast cancer

1 reference

12 December 2020

Estrogen receptors and the pattern of relapse in breast cancer

1 reference

12 December 2020

Tamoxifen and contralateral breast cancer

1 reference

12 December 2020

Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study

1 reference

12 December 2020

An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer

1 reference

12 December 2020

Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1988.245

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

3207602

1 reference